Merck (NYSE: MRK) stock has been a longtime winner for investors, returning 72% in the past five years. A major factor in ...

Merck has invested in digital infrastructure and tools in the past five years; we are now focused on building and scaling ... a research consortium led by MITRE. By connecting real-world patient ...

We recently compiled a list of the 7 Best Stocks for Beginners with Little Money According to Analysts. In this article, we ...

Approximately 40% of sales were due to doses administered to patients and the remainder were due to inventory building. Merck’s Animal ... of its key products led by Keytruda.

An experimental Merck & Co. drug aimed at the ... attacks that characterize HAE. The data build on prior results from Phase 1 testing, and led Intellia to choose a 50 milligram dose for a Phase ...

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

Merck (NYSE:MRK) announced Wednesday that the U.S. Food and Drug Administration (FDA) approved a label expansion for its ...

A pharmaceutical heir is traveling the globe selling multimillion-dollar apartments on his yet-to-be-built boat.

Earlier in his career, Mr. Powers held a hybrid role as Head of Real Estate and Infrastructure Operations as well as Strategy Program Manager for Merck Millipore’s Biosciences Division. He led ...

The Winrevair combination led to a statistically significant and clinically meaningful ... growing cardiovascular portfolio and pipeline and holds the potential to build upon Merck’s… legacy in ...

In the world of pharmaceuticals, companies aim to operate under GMP guidelines — a set of production and manufacturing ...

In a joint effort, a team led by Dr. Chris Lord and ... tankyrase programs at both ICR and Merck Serono and hope to ultimately translate these in to novel treatment options for cancer patients. We ...